Basecamp Wealth Advisors LLC
Position in FDMT — 4D Molecular Therapeutics, Inc.
CIK 2115254
BELLEVUE, WA
Position in FDMT
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$478
-$871 QoQ
Shares Held
36
-75.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#148
of 158 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in FDMT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Basecamp Wealth Advisors LLC holds $1,410,747 across 90 Biotechnology names. FDMT ranks #71 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
826 | $410,298 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
148 | $92,283 | |
| 3 | MRNA |
Moderna, Inc.
|
985 | $68,979 | |
| 4 | TECH |
BIO-TECHNE Corp
|
960 | $67,824 | |
| 5 | ARGX |
Argenx SE
|
61 | $56,593 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
296 | $55,434 | |
| 7 | RPRX |
Royalty Pharma plc
|
972 | $54,500 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
1,229 | $47,943 |
All Filings in FDMT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $478 | 36 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,349 | 145 | Shares | Sole | 2026-06-24 | |
| 2025-12-31 | $1,087 | 145 | Shares | Sole | 2026-06-24 | |
| No filing history on record for this holder in this stock. | ||||||